3H-Purin-6-amine 1-oxide(CAS: 700-02-7)

3H-Purin-6-amine 1-oxide (CAS: 700-02-7) falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS). In the European Union, it must comply with REACH regulations. For commercial and industrial use, FDA and EPA requirements also apply. Manufacturers and importers must ensure proper documentation, labeling, and handling to meet all regulatory standards.

Yes, there are alternative reagents and compounds that can be used in synthesis. For example, similar purine derivatives like 6-mercaptopurine or 6-methoxypurine can serve as alternatives. The choice of alternative depends on the specific application, such as drug synthesis or research. These alternatives offer similar functionality but with different chemical properties and reactivity.

The market for 3H-Purin-6-amine 1-oxide (CAS: 700-02-7) is driven by its applications in drug development, particularly as a precursor in the synthesis of purine-based drugs. Research trends indicate an increasing focus on developing more efficient and environmentally friendly synthesis methods. Additionally, there is growing interest in exploring its biological activities and potential therapeutic applications.

Waste containing 3H-Purin-6-amine 1-oxide (CAS: 700-02-7) should be collected in appropriate containers and disposed of through professional waste disposal services. Incineration is a common method for disposal, ensuring complete destruction and minimizing environmental impact. Environmental protection measures include proper containment to prevent leakage and adherence to local regulations for hazardous waste management.